340B Drug Pricing Program Contributes to Rising Healthcare Costs and Is Ripe for Reform
The U.S. House Energy & Commerce Committee's Health Subcommittee today will host the third hearing in its health care affordability series, specifically examining the role providers and hospitals play in shaping the cost of care for Americans.
While the hearing will likely examine numerous issues, there is none more ripe for reform than the flawed 340B drug pricing program.
Originally enacted to help eligible safety-net providers buy medicines at steep discounts and pass the savings on to lower-income and vulnerable patients, the program has ballooned as a revenue stream for many participating hospitals and contract pharmacy chains.
As the size and complexity of the 340B program has expanded, participating hospitals and contract pharmacies have instead used the program to increase…[more]
As the war in Ukraine begins its second year, a new Fox News poll shows Americans divided nearly down the middle over how much and how long the United States should support Ukraine in its war against Russian invaders.
The poll asked: "Do you think there should be a limited time frame for U.S. support of Ukraine in its fight against Russia, or should U.S. support continue as long as it takes for Ukraine to win?" Fifty percent of respondents said the U.S. should be in for as long as it takes, while 46% said there should be a limited time frame for U.S. support. Four percent said…
